OptimizeRx Corp [OPRX] stock prices are up 19.67% to $11.01 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The OPRX shares have gain 18.01% over the last week, with a monthly amount glided 35.42%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
OptimizeRx Corp [NASDAQ: OPRX] stock has seen the most recent analyst activity on January 08, 2025, when RBC Capital Mkts downgraded its rating to a Sector Perform and also revised its price target to $6 from $7. Previously, Stephens started tracking the stock with Equal-Weight rating on December 20, 2024, and set its price target to $5.50. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $15 on April 04, 2024. Barclays initiated its recommendation with a Equal Weight and recommended $15 as its price target on January 03, 2024. In a note dated November 01, 2022, Stifel initiated an Buy rating and provided a target price of $19 on this stock.
The stock price of OptimizeRx Corp [OPRX] has been fluctuating between $3.78 and $14.13 over the past year. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. OptimizeRx Corp [NASDAQ: OPRX] shares were valued at $11.01 at the most recent close of the market. An investor can expect a potential return of 36.24% based on the average OPRX price forecast.
Analyzing the OPRX fundamentals
The OptimizeRx Corp [NASDAQ:OPRX] reported sales of 94.37M for trailing twelve months, representing a surge of 11.37%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.11%, Pretax Profit Margin comes in at -0.17%, and Net Profit Margin reading is -0.16%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.13 and Total Capital is -0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.04 points at the first support level, and at 9.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.38, and for the 2nd resistance point, it is at 13.74.
Ratios To Look Out For
It’s worth pointing out that OptimizeRx Corp [NASDAQ:OPRX]’s Current Ratio is 2.82. Further, the Quick Ratio stands at 2.89, while the Cash Ratio is 0.9. Considering the valuation of this stock, the price to sales ratio is 2.16, the price to book ratio is 1.75.
Transactions by insiders
Recent insider trading involved Lang James Paul, Director, that happened on Mar 14 ’25 when 0.32 million shares were purchased. CEO, FEBBO WILLIAM J completed a deal on Dec 12 ’24 to buy 20000.0 shares.
